AlphaCentric Advisors LLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 119 filers reported holding SUTRO BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
AlphaCentric Advisors LLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2021$491,000
-2.2%
26,000
-3.7%
0.12%
-8.1%
Q2 2021$502,000
+451.6%
27,000
+575.0%
0.14%
+338.7%
Q1 2021$91,000
+4.6%
4,0000.0%0.03%
-13.9%
Q4 2020$87,0004,0000.04%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders